US Patent Issued to Katholieke Universiteit Leuven on Jan. 28 for "Heterocycle derivatives for treating TRPM3 mediated disorders" (Belgian, German Inventors)

ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,209,081, issued on Jan. 28, was assigned to Katholieke Universiteit Leuven (Leuven, Belgium).

"Heterocycle derivatives for treating TRPM3 mediated disorders" was invented by Patrick Chaltin (Zetrud-Lumay, Belgium), Arnaud Marchand (Bierbeek, Belgium), Jean-Christophe Vanherck (Leuven, Belgium), Thomas Voets (Kessel-Lo, Belgium), Joris Vriens (Wakkerzeel, Belgium), Melanie Reich (Wakkerzeel, Belgium) and Andre Welbers (Cologne, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to compounds that are useful for the prevention or treatment of TRPM3 mediated disorders, more in particular disorders selected from pain and inflammator...